Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PBIO will - over the next 2 Weeks and hit - by . In that time frame, PBIO's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
PBIO shares remained flat 0 in Friday, September 11, 2026's trading session, starting and closing at a previous close of $0.00 to move at $0.00. The stock demonstrated notable intraday movement (see PBIO's key stats for a full breakdown), fluctuating between $0.00 and $0.04, a +39,700.00% trading range. While recent weeks have seen some volatility, PBIO has managed to secure a -97.87% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 20K shares changing hands, 19.67K more than the previous session. This amounted to $2.00 in total market activity.
Will PBIO Continue Its Trend?
According to analyst ratings and projections for PBIO, Pressure BioSciences, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for PBIO currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 23 negative trading days within the past 30 sessions. Based on the PBIO stock forecast, now is not the best time to buy PBIO stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on PBIO covering social and institutional perspectives.
PBIO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PBIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.56% to 48.33%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.26%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.17%, maintains a neutral outlook for the long term. Insights into PBIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts

